NDC 0409-1810 - Novocaine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0409-1810
- Package NDCs from labels
- 0409-1810-02
- Manufacturer
- Hospira, Inc.
- Effective date
- 2007-08-28
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| NOVOCAIN ® PROCAINE HYDROCHLORIDE INJECTION, USP | Hospira, Inc. | 2007-08-28 | Human prescription drug label |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0409-1810-02 | Novocaine | 25 in 1 CARTON | INJECTION, SOLUTION | 25 | 2 | |
| 0409-1810-02 | Novocaine | 5 in 1 CONTAINER | INJECTION, SOLUTION | 5 | 2 | |
| 0409-1810-02 | Novocaine | 40 in 1 CASE | INJECTION, SOLUTION | 40 | 2 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Procaine Hydrochloride | ACTIVE INGREDIENT | 95URV01IDQ | NOVOCAINE (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 2 | |
| Procaine | ACTIVE MOIETY | 4Z8Y51M438 | NOVOCAINE (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 2 | |
| Acetone Sodium Bisulfite | INACTIVE INGREDIENT | NOVOCAINE (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cytarabine | CYTARABINE | Hospira, Inc. | 21e8e8e6-3f85-4fdd-8452-c9d14d2ef69a | 2026-08-27 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Heparin Sodium | HEPARIN SODIUM | Hospira, Inc. | c8c4edd2-ee9e-4558-6b8c-b83adc242a0a | 2026-08-25 | Warnings, Adverse reactions | Hospira, Inc. |
| Magnesium Sulfate in Water | MAGNESIUM SULFATE IN WATER | Hospira, Inc. | 22ca78b4-f5a3-4144-cf89-5f633acf1e6d | 2026-08-24 | Warnings, Adverse reactions | Hospira, Inc. |
| Fentanyl Citrate | FENTANYL CITRATE | Hospira, Inc. | bfa8018a-4cbc-434b-e09e-782872b0340a | 2026-08-24 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Magnesium Sulfate in Dextrose | MAGNESIUM SULFATE IN DEXTROSE | Hospira, Inc. | 03ebeabb-8386-4af4-3086-bdf3c3fc4a5a | 2026-08-24 | Warnings, Adverse reactions | Hospira, Inc. |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Hospira, Inc. | ad1ef0a8-88db-4648-c098-d009eaeb4e5b | 2026-08-20 | Warnings, Adverse reactions | Hospira, Inc. |
| QUELICIN | SUCCINYLCHOLINE CHLORIDE | Hospira, Inc. | fb08161e-7711-406d-e7b3-ea4515c07983 | 2026-08-18 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| PROPOFOL | PROPOFOL | Hospira, Inc. | 28d7ba00-f824-4e55-139a-03f509c099db | 2026-08-13 | Warnings, Adverse reactions | Hospira, Inc. |
| MIDAZOLAM | MIDAZOLAM HYDROCHLORIDE | Hospira, Inc. | b95415fa-17c2-42ab-a6b0-e628d01c94ed | 2026-08-12 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Midazolam | MIDAZOLAM HYDROCHLORIDE | Hospira, Inc. | 1abda8b8-48a8-4995-af86-39220d1aa240 | 2026-08-12 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Cytarabine | CYTARABINE | Hospira, Inc. | 277597b0-7d85-40a3-a34a-70c6a883fc6d | 2026-08-11 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| CYTARABINE | CYTARABINE | Hospira, Inc. | 681b5dc4-4fcf-4fab-ad78-02cb9a4a5dd0 | 2026-08-11 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Vitamin K1 | PHYTONADIONE | Hospira, Inc. | e8808230-2c44-44c6-8cab-8f29b6b34051 | 2026-08-09 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Oxaliplatin | OXALIPLATIN | Hospira, Inc. | e51a62ba-d163-4c57-835c-8c86cf097e40 | 2026-08-07 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Cytarabine | CYTARABINE | Hospira, Inc. | bc2fa221-ea56-48b8-8304-42cd81b8463b | 2026-08-06 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Hospira, Inc. | 3b2dd84e-cee8-4e58-d494-395a65a353a0 | 2026-08-05 | Warnings, Adverse reactions | Hospira, Inc. |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Hospira, Inc. | 9c18eaf1-4a0b-4916-70b2-88a827494711 | 2026-08-05 | Warnings, Adverse reactions | Hospira, Inc. |
| Ketorolac Tromethamine | KETOROLAC TROMETHAMINE | Hospira, Inc. | 8accbb78-fc64-45d5-69b0-35c23a1d2a2e | 2026-07-20 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Vancomycin Hydrochloride | VANCOMYCIN HYDROCHLORIDE | Hospira, Inc. | b01aaa02-8f1d-4b57-96a5-337503428af1 | 2026-07-20 | Warnings, Adverse reactions | Hospira, Inc. |
| DEMEROL | MEPERIDINE HYDROCHLORIDE | Hospira, Inc. | b31d1308-28c3-43f4-e0a6-2f3ed76b8975 | 2026-07-20 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.